ClinConnect ClinConnect Logo
Search / Trial NCT05379530

TEG Use in Children Undergoing Procedures With High Anticipated Blood Loss

Launched by BOSTON CHILDREN'S HOSPITAL · May 13, 2022

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Thromboelastography Blood Transfusion Viscoelastic Test Guided Massive Hemorrhage

ClinConnect Summary

This clinical trial is studying the use of a tool called Thromboelastography (TEG) to help doctors manage blood loss during certain surgeries in children. TEG can help assess how well a child's blood is clotting, which is important because both too much and too little blood transfusion can be risky, especially for kids who may have smaller blood volumes. The researchers want to see how effective TEG can be for children undergoing non-cardiac surgeries that have a high chance of needing blood transfusions, like spinal surgeries or liver transplants.

To participate in this study, children must be undergoing specific types of planned surgeries at Boston Children's Hospital that are expected to have more than a 25% chance of requiring a blood transfusion. Unfortunately, children undergoing emergency surgeries or those who need cardiac procedures won’t be eligible. If a child qualifies, their doctors will use TEG during the surgery to gather information that may help improve care and outcomes. The study is not yet recruiting participants, but it aims to improve how blood loss is managed in pediatric surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pediatric patients undergoing non-cardiac surgery at BCH with a high likelihood of blood transfusion. Specifically these are defined as a surgery with greater than 25% likelihood of transfusion of any non-albumin blood product.
  • * Eligible surgeries include:
  • spinal surgery
  • laparotomy
  • liver transplant
  • craniofacial surgery
  • esophageal atresia
  • craniotomy/hemispherectomy
  • major abdominal surgery
  • major hip surgery
  • major plastic surgery
  • Exclusion Criteria:
  • Patients undergoing cardiac surgery or ECMO cannulation, as these surgeries are generally considered outside the scope of general pediatric surgery.
  • Patients presenting for emergent surgery
  • Patients undergoing surgeries off hours (between 8pm and 8 am), when TEG analysis is unobtainable

About Boston Children's Hospital

Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials